Drug News
High Risk of Pulmonary Embolism Seen in Severe Asthma
Patients with asthma are at higher risk of pulmonary embolism, particularly if the asthma is severe or they take oral corticosteroids.
Your search for oral corticosteroids returned 13 results
Drugs in the Pipeline
Rituxan Gets Breakthrough Therapy Status for Rare Autoimmune Skin Disorder
Genentech announced that the Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Rituxan (rituximab) for the treatment of pemphigus vulgaris.
Drug News
FDA Panel Says No to OTC Singulair
A panel of expert advisors to the U.S. Food and Drug Administration voted overwhelmingly against moving the allergy drug Singulair from prescription to over-the-counter status.
Drugs in the Pipeline
Fast Track Designation Granted for OrbeShield in GI ARS
Soligenix announced today that the FDA has designated its OrbShield (oral beclomethasone 17, 21-dipropionate or oral BDP) development program for the treatment of Gastrointestinal Acute Radiation Syndrome (GI ARS), for Fast Track review.
Drug News
In Long-Term COPD Maintenance, Can Roflumilast as Add-On Tx Reduce Exacerbations?
While use of an inhaled corticosteroid + long-acting beta2-agonist (LABA) is recommended for long-term maintenance treatment of airflow obstruction in COPD, the efficacy of roflumilast as an add-on treatment to these medications as maintenance therapy is unknown.
News
New Treatment Option for Recurrent Nasal Polyps Gets FDA Approval
The Sinuva Sinus Implant is a corticosteroid-eluting (mometasone furoate) implant indicated for the treatment of nasal polyps.
News
FDA Approves Updated ONJ Warning for Prolia, Xgeva
The Food and Drug Administration (FDA) has approved supplemental Biologics License Applications (sBLA) for Amgen's Prolia (denosumab) and Xgeva (denosumab).
News
ArmonAir Digihaler Approved for Asthma Maintenance Treatment
The FDA has approved ArmonAir® Digihaler (fluticasone propionate; Teva) for the maintenance treatment of asthma as prophylactic therapy in patients 12 years of age and older.
News
Single Inhaler Triple Therapy Approved for COPD
Trelegy Ellipta combines fluticasone furoate, an inhaled corticosteroid with umeclidinium, an anticholinergic and vilanterol, a long-acting β2-adrenergic agonist (LABA).
Drug News
New Guidelines Issued for Management of Gout
Approaches for management of gout are presented in a two-part guideline.
